Chuyên gia Nhật Bản khuyến nghị dùng thuốc kháng virus của Merck

Ngày 24/12, một hội đồng thuộc Bộ Y tế Nhật Bản đã khuyến nghị cấp phép sử dụng thuốc kháng virus do hãng dược Merck & Co Inc (Mỹ) phát triển. Đây là một phần trong các kế hoạch của Thủ tướng Kishida Fumio dự định triển khai trong năm tới để điều trị cho các bệnh nhân COVID-19, trong bối cảnh những lo ngại ngày một gia tăng liên quan biến thể Omicron của virus SARS-CoV-2.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh